Chuyên gia Nhật Bản khuyến nghị dùng thuốc kháng virus của Merck

Ngày 24/12, một hội đồng thuộc Bộ Y tế Nhật Bản đã khuyến nghị cấp phép sử dụng thuốc kháng virus do hãng dược Merck & Co Inc (Mỹ) phát triển. Đây là một phần trong các kế hoạch của Thủ tướng Kishida Fumio dự định triển khai trong năm tới để điều trị cho các bệnh nhân COVID-19, trong bối cảnh những lo ngại ngày một gia tăng liên quan biến thể Omicron của virus SARS-CoV-2.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh